Chuyên gia Nhật Bản khuyến nghị dùng thuốc kháng virus của Merck

Ngày 24/12, một hội đồng thuộc Bộ Y tế Nhật Bản đã khuyến nghị cấp phép sử dụng thuốc kháng virus do hãng dược Merck & Co Inc (Mỹ) phát triển. Đây là một phần trong các kế hoạch của Thủ tướng Kishida Fumio dự định triển khai trong năm tới để điều trị cho các bệnh nhân COVID-19, trong bối cảnh những lo ngại ngày một gia tăng liên quan biến thể Omicron của virus SARS-CoV-2.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh